Authors/Disclosures
|
|
No disclosure on file |
|
J. P. Mohr, MD, FAAN
(Neurological Institute)
|
The institution of Dr. Mohr has received research support from NINDS Grant R01 NS099268 NIH-NINDS . |
|
|
No disclosure on file |
|
Wayne M. Clark, MD
(Oregon Health Sciences Univ)
|
Dr. Clark has nothing to disclose. |
|
Frank L. Silver, MD
(Univ Health Network, Toronto Western Hosp)
|
Dr. Silver has nothing to disclose. |
|
Ariane E. Mackey, MD
(Hop De L'Enfant-Jesus Neuro)
|
No disclosure on file |
|
Connie Lau, MS, CCRC
|
No disclosure on file |
|
Michael D. Hill, MD
(University of Calgary)
|
Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular. |
|
James F. Meschia, MD, FAAN
(Mayo Clinic)
|
The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS. |
|
Alice J. Sheffet, PhD
(CREST Administrative CenterRutgers, the State University of New Jersey)
|
No disclosure on file |
|
Thomas G. Brott, MD, FAAN
(Mayo Clinic)
|
Dr. Brott has nothing to disclose. |